Your browser doesn't support javascript.
loading
Financial incentives to improve glycemic control in African American adults with type 2 diabetes: a pilot randomized controlled trial.
Egede, Leonard E; Campbell, Jennifer A; Walker, Rebekah J; Dawson, Aprill Z; Williams, Joni S.
Afiliação
  • Egede LE; Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, 701 Watertown Plank Rd, Milwaukee, WI, 53226-3596, USA. legede@mcw.edu.
  • Campbell JA; Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA. legede@mcw.edu.
  • Walker RJ; Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, 701 Watertown Plank Rd, Milwaukee, WI, 53226-3596, USA.
  • Dawson AZ; Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Williams JS; Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, 701 Watertown Plank Rd, Milwaukee, WI, 53226-3596, USA.
BMC Health Serv Res ; 21(1): 57, 2021 Jan 13.
Article em En | MEDLINE | ID: mdl-33435969
ABSTRACT

BACKGROUND:

Financial incentives is emerging as a viable strategy for improving clinical outcomes for adults with type 2 diabetes. However, there is limited data on optimal structure for financial incentives and whether financial incentives are effective in African Americans with type 2 diabetes. This pilot study evaluated impact of three financial incentive structures on glycemic control in this population.

METHODS:

Sixty adults with type 2 diabetes were randomized to one of three financial incentive structures 1) single incentive (Group 1) at 3 months for Hemoglobin A1c (HbA1c) reduction, 2) two-part equal incentive (Group 2) for home testing of glucose and HbA1c reduction at 3 months, and 3) three-part equal incentive (Group 3) for home testing, attendance of weekly telephone education classes and HbA1c reduction at 3 months. The primary outcome was HbA1c reduction within each group at 3 months post-randomization. Paired t-tests were used to test differences between baseline and 3-month HbA1c within each group.

RESULTS:

The mean age for the sample was 57.9 years and 71.9% were women. Each incentive structure led to significant reductions in HbA1c at 3 months with the greatest reduction from baseline in the group with incentives for multiple components Group 1 mean reduction = 1.25, Group 2 mean reduction = 1.73, Group 3 mean reduction = 1.74.

CONCLUSION:

Financial incentives led to significant reductions in HbA1c from baseline within each group. Incentives for multiple components led to the greatest reductions from baseline. Structured financial incentives that reward home monitoring, attendance of telephone education sessions, and lifestyle modification to lower HbA1c are viable options for glycemic control in African Americans with type 2 diabetes. TRIAL REGISTRATION Trial registration NCT02722499 . Registered 23 March 2016, url.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Motivação Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Motivação Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article